Serum fibroblast growth factor 19 (FGF19) levels are associated with atherogenic dyslipidemia in patients with type 2 diabetes

by Jing-Yi Hu, Hai-Lan Zou, Yan-Hua Li, Dong-Ying Nie, Chen Chao, Jin-Han Liu, Jin Ding, Zhi-Guang Zhou, Yang Xiao, Ning-Ning Wang
Published 2021-09-01